-
Mashup Score: 1Shockwave Peripheral IVL: Size for Success - Endovascular Today - 1 month(s) ago
Oversizing by 10% for optimal peripheral IVL results.
Source: evtoday.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0BYOOVIZ® (ranibizumab nuna) and the Age of Biosimilars - Eyetube - 1 month(s) ago
What do retina specialists need to know about biosimilars in general and BYOOVIZ in particular? Sit down with Anat Loewenstein, MD, and David Brown, MD, as they explore this new era in retina.
Source: eyetube.netCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 4Safety. Effectiveness. Evidence. SEE Why Inari Is the Preferred Choice for VTE Intervention - Endovascular Today - 2 month(s) ago
Case reports and discussions with experts highlight the utility of the FlowTriever and ClotTriever Systems for your venous thromboembolism practice.
Source: evtoday.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 3Keratometry Readings With SS-OCT Biometers and Their Impact on IOL Power Calculations - 2 month(s) ago
Thanks for visiting CRSToday. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated. In order to avoid adverse performance issues with this site, please white list https://crstoday.com in your ad blocker then refresh this page. Keratometry readings are important parameters needed to determine the exact IOL power. Different SS-OCT biometers employ different approaches to measure the corneal curvature, which leads to slightly different
Source: crstoday.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 0Roundtable Discussion: Chronic Venous Disease Treatment Options - Endovascular Today - 2 month(s) ago
Ramona Gupta, MD, FSIR Associate Professor of Radiology, Section of Interventional Radiology, Northwestern University Feinberg School of Medicine
Source: evtoday.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0Improving Interoperability and Health Equity With Health Information Exchange Networks - MedCity News - 2 month(s) ago
In a webinar sponsored by DocuSign, scheduled for April 16 at 1 pm ET, DocuSign will discuss the benefits of its collaboration with the Michigan Health Information Exchange Network’s (MHIEN) arm, Velatura and how it can function as a model for interoperability.
Source: medcitynews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Insertion Pearls for The HYDRUS Microstent - Glaucoma Today - 2 month(s) ago
When it comes to MIGS procedures, anatomy is key. As far as physiologic drainage pathways are concerned, MIGS implants must bypass the trabecular mesh
Source: glaucomatoday.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 0Why it matters to perform cataract surgery at near physiologic IOP – EyeWorld Corporate Education - 2 month(s) ago
Moderators and faculty are paid consultants of
Source: meetings.eyeworld.orgCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 1February 2024 Supplement - Endovascular Today - 2 month(s) ago
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
Source: evtoday.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0Plug-Assisted Embolization of an Accessory Left Gastric Artery to Prevent Nontarget Organ Injury During Y90 Radioembolization - Endovascular Today - 2 month(s) ago
Sanjeeva Kalva, MBBS, MD, FSIR, FCIRSE, FACR Massachusetts General Hospital Boston, Massachusetts skalva@mgh.harvard.edu Transarterial radio
Source: evtoday.comCategories: General Medicine News, Cardiology News and JournTweet
Drs. Sasanka Jayasuriya (@SJcardio) & Paul J. Foley III discuss the value of oversizing by 10% to achieve optimal results with peripheral intravascular lithotripsy and share recent case examples using the Shockwave IVL system. #Sponsored by @ShockwaveIVL https://t.co/IWk5XPa7QB